M. Kobayashi, S. Okamoto / Tetrahedron Letters 47 (2006) 4347–4350
4349
pounds, and [DMAP–Ac]+ may be expected to be rela-
tively less stable. These assumptions are in good
agreement with the results of NMR experiments for
Eq. 2 mentioned above. Moreover, it may be considered
that pyrimido derivatives 1b and 2b could be acylated
easier than the corresponding imidazo derivatives 1a
and 2a, respectively. Acylated 2b is much more stable
than acylated 2a, presumably due to a larger ring strain
of acylated 2a than that of acylated 2b. Although the
confirmation of details of the mechanism must await
further study, it may totally be assumed that easy gener-
ation of the acylated intermediate from 2b due to a large
energy gain by delocalizing stabilization of the generated
positive charge might mainly affect the catalytic activity
of 2b.
In summary, we have investigated the reactivity of annu-
lated benzothiazol-2-ylidenamines 2 as an acyl transfer
catalyst and found that the dihydropyrimido derivative
of benzothiazole 2b exhibited extremely high activity,
which might be a good candidate as a reactive core for
development of an asymmetric catalyst.
Acknowledgements
We thank Professor Vladimir B. Birman, Washington
University, St. Louis, for valuable comments and discus-
sion through private communication.
Figure 3. 500 MHz 1H NMR spectra for a 1:1 mixture of 2a and Ac2O
(the upper spectra) or for a 1:1 mixture of 2b and Ac2O (the lower
spectra) in CDCl3 at room temperature.
ene ring. Interestingly, although the spectra of a mixture
of 2b and Ac2O involved one set of peaks corresponding
to an acylated intermediate, those of a mixture of 2a and
Ac2O were much more complicated. The different
behaviors thus observed for 2a and 2b cannot be ex-
plained at this time but may reflect the difference of their
relative catalytic activity.
References and notes
1. Recent reviews: Vedejs, E.; Jure, M. Angew. Chem., Int.
Ed. 2005, 44, 3974; Dalko, P. I.; Moisan, L. Angew.
Chem., Int. Ed. 2004, 43, 5138; France, S.; Guerin, D. J.;
Miller, S. J.; Lectka, T. Chem. Rev. 2003, 103, 2985.
2. Birman, V. B.; Uffman, E. W.; Jiang, H.; Li, X.; Kilbane,
C. J. J. Am. Chem. Soc. 2004, 126, 12226; Birman, V. B.;
Jiang, H. Org. Lett. 2005, 7, 3445.
To consider the large difference of catalytic reactivity
between 2a and 2b, we tried to estimate energy differ-
ences among catalyst compounds and their acylated
intermediates by calculation using molecular mechanics
(MM2).10 From the results shown in Figure 4, acylation
of 2b seems to be much easier than that of other com-
3. Birman, V. B.; Li, X. Org. Lett. 2006, 8, 1351.
4. Young, R. C.; Mitchell, R. C.; Brown, T. H.; Ganellin, C.
R.; Griffiths, R.; Jones, M.; Rana, K. K.; Saunders, D.;
Smith, T. R.; Sore, N. E.; Wilks, T. J. J. Med. Chem. 1988,
31, 656; Abstract for Anisimova, V. A.; Levchenko, M. V.
Khimiya Geterotsiklicheskikh Soedinenii 1987, 59.
5. Compound 2a: 1H NMR (600 MHz, CDCl3) d 7.26
(d, J = 7.6 Hz, 1H), 7.19 (t, J = 7.5 Hz, 1H), 6.95
(t, J = 7.6 Hz, 1H), 6.67 (d, J = 7.6 Hz, 1H), 4.35
(t, J = 8.9 Hz, 2H), 3.85 (t, J = 8.9 Hz, 2H); 13C NMR
(150 MHz, CDCl3) d 162.7, 138.2, 127.3, 124.7, 122.8,
122.5, 110.7, 42.6, 40.9. 2b: 1H NMR (600 MHz, CDCl3) d
7.27 (d, J = 7.6 Hz, 1H), 7.20 (dd, J = 7.6, 8.2 Hz, 1H),
7.00 (t, J = 7.6 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 3.79 (t,
J = 6.2 Hz, 2H), 3.55 (t, J = 5.7 Hz, 2H), 2.01 (m, 2H);
13C NMR (150 MHz, CDCl3) d 159.2, 140.0, 126.2, 122.4
(2C), 121.9, 108.1, 44.1, 42.6, 19.3. Compound 1b: 1H
NMR (500 MHz, CDCl3) d 6.85 (d, J = 6.9 Hz, 1H), 6.67
(t, J = 6.3 Hz, 1H), 6.04 (d, J = 9.8 Hz, 1H), 5.57 (t,
J = 6.9 Hz, 1H), 3.74 (t, J = 6.3 Hz, 2H), 3.28 (t,
J = 6.3 Hz, 2H), 1.77 (m, 2H); 13C NMR (125 MHz,
CDCl3) d 151.0, 136.8, 132.9, 122.7, 103.2, 49.5, 43.3, 20.0.
6. Version 1.63 for Macintosh was used. This is available
O
N+
N
n
N+
N
n
O
N+
N
1a (n=0)
1b (n=1)
-15.4
-16.8
-10.6
-22.1
N+
S
N+
S
n
n
N
N
O
O
O
-9.85
DMAP
-12.0
-23.7
2a (n=0)
2b (n=1)
-14.8
-25.5
Figure 4. The preliminary results of calculation of energy differences
between catalyst compound and the acylated derivative: Cat. to [Cat.–
Ac]+ (kcal/mol).